TY - JOUR
T1 - The implantable cardioverter defibrillator
AU - Glikson, Michael
AU - Friedman, Paul A.
PY - 2001/4/7
Y1 - 2001/4/7
N2 - Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk patients include those who have survived life-threatening arrhythmias, and individuals with cardiac diseases who are at risk for such arrhythmias, but are symptomless. Use of an ICD will affect the patient's quality of life. Some drugs can substantially affect defibrillator function and efficacy, and possible drug-device interactions should be considered. Patients with ICDs may encounter cell phones, antitheft detectors, and many other sources of potential electromagnetic interference. In addition to treating ventricular tachyarrhythmias, new defibrillators provide full featured dual chamber pacing, and could treat atrial arrhythmias, and congestive heart failure by means of biventricular pacing.
AB - Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk patients include those who have survived life-threatening arrhythmias, and individuals with cardiac diseases who are at risk for such arrhythmias, but are symptomless. Use of an ICD will affect the patient's quality of life. Some drugs can substantially affect defibrillator function and efficacy, and possible drug-device interactions should be considered. Patients with ICDs may encounter cell phones, antitheft detectors, and many other sources of potential electromagnetic interference. In addition to treating ventricular tachyarrhythmias, new defibrillators provide full featured dual chamber pacing, and could treat atrial arrhythmias, and congestive heart failure by means of biventricular pacing.
UR - http://www.scopus.com/inward/record.url?scp=0035820297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035820297&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(00)04263-X
DO - 10.1016/S0140-6736(00)04263-X
M3 - Review article
C2 - 11297981
AN - SCOPUS:0035820297
SN - 0140-6736
VL - 357
SP - 1107
EP - 1117
JO - Lancet
JF - Lancet
IS - 9262
ER -